AIMS/HYPOTHESIS: Previous studies on isolated islets have demonstrated tight coupling between calcium (Ca(2+)) influx and oxygen consumption rate (OCR) that is correlated with insulin secretion rate (ISR). To explain these observations, we have proposed a mechanism whereby the activation of a highly energetic process (Ca(2+)/metabolic coupling process [CMCP]) by Ca(2+) mediates the stimulation of ISR. The aim of the study was to test whether impairment of the CMCP could play a role in the development of type 2 diabetes. METHODS: Glucose- and Ca(2+)-mediated changes in OCR and ISR in isolated islets were compared with the time course of changes of plasma insulin concentrations observed during the progression to hyperglycaemia in a rat model of type-2 diabetes (the University of California at Davis type 2 diabetes mellitus [UCD-T2DM] rat). Islets were isolated from UCD-T2DM rats before, 1 week, and 3 weeks after the onset of hyperglycaemia. RESULTS: Glucose stimulation of cytosolic Ca(2+) and OCR was similar for islets harvested before and 1 week after the onset of hyperglycaemia. In contrast, a loss of decrement in islet OCR and ISR in response to Ca(2+) channel blockade coincided with decreased fasting plasma insulin concentrations observed in rats 3 weeks after the onset of hyperglycaemia. CONCLUSIONS/ INTERPRETATION: These results suggest that phenotypic impairment of diabetic islets in the UCD-T2DM rat is downstream of Ca(2+) influx and involves unregulated stimulation of the CMCP. The continuously elevated levels of CMCP induced by chronic hyperglycaemia in these islets may mediate the loss of islet function.
AIMS/HYPOTHESIS: Previous studies on isolated islets have demonstrated tight coupling between calcium (Ca(2+)) influx and oxygen consumption rate (OCR) that is correlated with insulin secretion rate (ISR). To explain these observations, we have proposed a mechanism whereby the activation of a highly energetic process (Ca(2+)/metabolic coupling process [CMCP]) by Ca(2+) mediates the stimulation of ISR. The aim of the study was to test whether impairment of the CMCP could play a role in the development of type 2 diabetes. METHODS:Glucose- and Ca(2+)-mediated changes in OCR and ISR in isolated islets were compared with the time course of changes of plasma insulin concentrations observed during the progression to hyperglycaemia in a rat model of type-2 diabetes (the University of California at Davis type 2 diabetes mellitus [UCD-T2DM] rat). Islets were isolated from UCD-T2DM rats before, 1 week, and 3 weeks after the onset of hyperglycaemia. RESULTS:Glucose stimulation of cytosolic Ca(2+) and OCR was similar for islets harvested before and 1 week after the onset of hyperglycaemia. In contrast, a loss of decrement in islet OCR and ISR in response to Ca(2+) channel blockade coincided with decreased fasting plasma insulin concentrations observed in rats 3 weeks after the onset of hyperglycaemia. CONCLUSIONS/ INTERPRETATION: These results suggest that phenotypic impairment of diabetic islets in the UCD-T2DM rat is downstream of Ca(2+) influx and involves unregulated stimulation of the CMCP. The continuously elevated levels of CMCP induced by chronic hyperglycaemia in these islets may mediate the loss of islet function.
Authors: Ian R Sweet; Gamal Khalil; Angela R Wallen; Mark Steedman; Kenneth A Schenkman; Jo Anna Reems; Steven E Kahn; James B Callis Journal: Diabetes Technol Ther Date: 2002 Impact factor: 6.118
Authors: Ian R Sweet; Daniel L Cook; Eric DeJulio; Angela R Wallen; Gamal Khalil; James Callis; JoAnna Reems Journal: Diabetes Date: 2004-02 Impact factor: 9.461
Authors: Ian R Sweet; Daniel L Cook; Robert W Wiseman; Carla J Greenbaum; Ake Lernmark; Shinichi Matsumoto; Jeanette C Teague; Kenneth A Krohn Journal: Diabetes Technol Ther Date: 2002 Impact factor: 6.118
Authors: Jakob D Wikstrom; Samuel B Sereda; Linsey Stiles; Alvaro Elorza; Emma M Allister; Andy Neilson; David A Ferrick; Michael B Wheeler; Orian S Shirihai Journal: PLoS One Date: 2012-05-14 Impact factor: 3.240
Authors: Austin M Rountree; Adam S Neal; Mark Lisowski; Norma Rizzo; Jared Radtke; Sarah White; Dan S Luciani; Francis Kim; Christiane S Hampe; Ian R Sweet Journal: J Biol Chem Date: 2014-05-19 Impact factor: 5.157
Authors: Rebecca L Hull; Ronald L Gibson; Sharon McNamara; Gail H Deutsch; Corinne L Fligner; Charles W Frevert; Bonnie W Ramsey; Srinath Sanda Journal: Diabetes Care Date: 2018-02-01 Impact factor: 19.112
Authors: Akos A Gerencser; Shona A Mookerjee; Martin Jastroch; Martin D Brand Journal: Biochim Biophys Acta Mol Basis Dis Date: 2016-10-20 Impact factor: 5.187
Authors: Adam Neal; Austin Rountree; Kelly Kernan; Brian Van Yserloo; Huiliang Zhang; Benjamin J Reed; William Osborne; Wang Wang; Ian R Sweet Journal: Biochem J Date: 2016-10-11 Impact factor: 3.857
Authors: Richard G Peterson; Charles V Jackson; Karen Zimmerman; Willem de Winter; Norman Huebert; Michael K Hansen Journal: J Diabetes Res Date: 2015-04-16 Impact factor: 4.011
Authors: Marika Bogdani; Pamela Y Johnson; Susan Potter-Perigo; Nadine Nagy; Anthony J Day; Paul L Bollyky; Thomas N Wight Journal: Diabetes Date: 2014-03-27 Impact factor: 9.461
Authors: Varun Kamat; Brian M Robbings; Seung-Ryoung Jung; John Kelly; James B Hurley; Kenneth P Bube; Ian R Sweet Journal: Elife Date: 2021-11-04 Impact factor: 8.140